According to AIM ImmunoTech 's latest financial reports the company's current revenue (TTM ) is โน14.53 Million. In 2022 the company made a revenue of โน11.58 Million an increase over the revenue in the year 2021 that were of โน9.97 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.